A detailed history of Horizon Investments, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Horizon Investments, LLC holds 10 shares of UTHR stock, worth $3,643. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 7 42.86%
Holding current value
$3,643
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$311.04 - $363.55 $933 - $1,090
3 Added 42.86%
10 $3,000
Q1 2024

May 15, 2024

BUY
$210.76 - $249.51 $843 - $998
4 Added 133.33%
7 $1,000
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $214 - $256
1 Added 50.0%
3 $0
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $425 - $552
2 New
2 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Horizon Investments, LLC Portfolio

Follow Horizon Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.